Abstract:Imaging of apoptosis can allow noninvasive assessment of disease states and response to therapeutic intervention for a variety of diseases. The purpose of this study was to develop and evaluate a multimodal nanoplatform for the detection of apoptosis. Methods: To modulate the pharmacokinetics of annexin A5, a 36-kDa protein that binds specifically with phosphatidylserine, annexin A5 was conjugated to polyethylene glycol-coated, core-cross-linked polymeric micelles (CCPMs) dually labeled with near-infrared fluorescence fluorophores and a radioisotope (In-111). To evaluate the specificity of the binding of annexin A5-CCPM to apoptotic cells, both fluorescence microscopy and cell-binding studies were performed in vitro. Pharmacokinetics, biodistribution, dual nuclear and optical imaging, and immunohistochemical studies were performed in 2 xenografted tumor models to evaluate the potential applications of annexin A5-CCPM. Results: In cell-based studies, annexin A5-CCPM exhibited strongly specific binding to apoptotic tumor cells. This binding could be efficiently blocked by annexin A5. In mice, annexin A5-CCPM displayed a mean elimination half-life of 12.5 h. The mean initial concentration in blood was 22.4% of the injected dose/mL, and annexin A5-CCPM was mainly distributed in the central blood compartment. In mice bearing EL4 lymphoma treated with cyclophosphamide and etoposide and in mice bearing MDA-MB-468 breast tumors treated with poly(L-glutamic acid)-paclitaxel and cetuximab (IMC-C225) anti-epidermal growth factor receptor antibody, the tumor apoptosis was clearly visualized by both SPECT and fluorescence molecular tomography. In contrast, there was little accumulation of this nanoradiotracer in the tumors of untreated mice. The biodistribution data were consistent with the imaging data, with tumor-to-muscle and tumor-to-blood ratios of 38.8 and 4.1, respectively, in treated mice, and 14.8 and 2.2, respectively, in untreated mice bearing EL4 lymphoma. Moreover, further studies demonstrated that the conventional Tc-99m-labeled hydrazinonicotinamide annexin A5 and the plain CCPM control exhibited significantly lower uptake in the tumors of the treated mice than annexin A5-CCPM. Immunohistochemistry staining study showed that radioactivity count correlated with fluorescence signal from the nanoparticles, and both signals colocalized with the region of tumor apoptosis. Conclusion: Annexin A5-CCPM allowed visualization of tumor apoptosis by both nuclear and optical techniques. The complementary information acquired with multiple imaging techniques should be advantageous in assessing and validating early response to therapy.

Detection of tumor cell apoptosis induced by chemotherapy with 99Tcm-Annexin B1

Detection of Tumor Apoptotic Response in Vivo after a Single Dose of Chemotherapy with 99Tcm-Rh-annexin V

New method for the analysis of cell cycle-specific apoptosis.

Experimental Study on Tumor Response to Chemotherapy with 18F-Sfb-annexin B1

Detection of Tumor Cell Apoptosis with 99Tcm-Rh-annexin V after Radiotherapy or Chemotherapy

Experimental study on tumor cell apoptosis imaging in vivo with 99Tcm-HYNIC-Annexin Ⅴ in mice tumor-bearing

Preparation and bioevaluation of 99mTc-Annexin B1 as a novel radiotracer for apoptosis imaging

99Tcm-Tp5-3 Microspect/ct for the Early Evaluation of Response in Mice Bearing MDA-MB-231 Breast Carcinoma after a Single Dose of Paclitaxel Chemotherapy

Distribution of ~(99)Tc~m-rh-Annexin Ⅴ in Tumor and Expression Relationship of bcl-2, bax After a Single Dose of Chemotherapy

Distribution of 99Tcm-rh-Annexin Ⅴ and its relationship with expression of Survivin and Caspase-3 in tumors after a single dose of chemotherapy

Detection of Cell Apoptosis Induced by 125I Brachytherapy in Nude Mice Bearing Lung Adenocarcinoma Using 99Tcm-Annexin V Imaging Combined with Diffusion Weighted MRI

Distribution of 99Tcm-rh-Annexin V and its relationship with expression of bcl-2,bax in tumor early after radiotherapy

99mTc-HYNIC-Annexin V detection of apoptosis in the rabbit model of liver cancer

Preparation, in Vitro and in Vivo Evaluation of (99M)tc-Annexin B1: a Novel Radioligand for Apoptosis Imaging.

Monitoring Apoptosis of Breast Cancer Xenograft After Paclitaxel Treatment With 99mTc-Labeled Duramycin SPECT/CT

Study on Mice Tumor-Bearing Cell Apoptosis Imaging in Vivo after a Single Dose of Chemotherapy

In Vivo99mtc-Hynic-annexin V Imaging of Early Tumor Apoptosis in Mice after Single Dose Irradiation

Preparation and bioevaluation of 88Tcm-HYNIC-Annexin B1 as a novel radiotracer for apoptosis detection

In Vivo Imaging of Radiation Induced Apoptosis

Annexin A5-conjugated polymeric micelles for dual SPECT and optical detection of apoptosis.

The Study on Tumor Cell Apoptotic Imaging in Vivo with 99Tcm-Hynic-annexin V in Mice Tumor-Bearing